Tecan has teamed up with Technoclone and the University Children's Hospital in Zurich to validate the Technothrombin thrombin generation assay (TGA) for Tecan's Infinite M200 microplate reader.
Dr Oliver Speer, head of the Experimental Hematology and Erythrocyte Laboratory at the hospital, explained: 'We installed the Infinite reader in our laboratory to standardise all of our photometric assays using just a single platform.
'Once we had completed the transfer of our existing assays to the Infinite, we realised that the flexibility and sensitivity of the instrument would allow us to supersede some of these assays with more efficient or sensitive methods, so became interested in the Technothrombin TGA.
'Representatives from Tecan and Technoclone came to the hospital to assist with development and validation of this assay on the Infinite reader, enabling us to very quickly complete our validation study.
'The collaboration between the two companies was perfect for us, and we are still in regular contact with Tecan for technical assistance.
'The support we have received has been excellent, and Tecan has even developed the software specifically for our needs,' he added.
